Explore the emerging relationship between clonal hematopoiesis and cancer genetics, and its growing impact on precision oncology.

In this on-demand Spotlight interview, Dr. Karina Eterovic discusses how clonal hematopoiesis is reshaping our understanding of cancer biology, aging, and genomic testing. Learn how advances in molecular profiling are improving cancer diagnostics, informing treatment decisions, and supporting the development of precision medicine strategies.

In this interview, you'll learn:

• What clonal hematopoiesis is and how it is linked to cancer development
• The implications of clonal hematopoiesis for genomic testing and precision oncology
• How advances in molecular profiling are shaping cancer diagnostics and treatment strategies
• Emerging research and future directions in cancer genetics and precision medicine

As cancer genomics continues to evolve, understanding clonal hematopoiesis is becoming increasingly important for accurate molecular interpretation and personalized patient care. Discover how ongoing research is advancing precision oncology and helping shape the future of cancer diagnostics and therapeutic development.